After President Trump touted it as a quote "cure" for coronavirus, Regeneron is seeking emergency use authorization for its antibody treatment. This treatment is still in testing and has not been approved for widespread use. The drugmaker says it has seen an uptick in interest from people wanting to participate in the trial. For more on the latest coronavirus antibody treatments, we spoke to Doctor Jennifer Bath, expert in antibody based therapeutics and the CEO of ImmunoPrecise, a company that specializes in finding and creating antibody treatments.